Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -396,932 | -446,806 | -551,040 | -72,000 | -77,082 |
| Other Working Capital | -75,551 | -510,411 | -407,680 | 941,000 | 829,317 |
| Other Operating Activity | 6,429,373 | 5,658,320 | 5,810,560 | 2,191,000 | 3,856,841 |
| Operating Cash Flow | $5,956,890 | $4,701,103 | $4,851,840 | $3,060,000 | $4,609,076 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -848,494 | -769,527 | -819,280 | -1,167,000 | -986,234 |
| Net Acquisitions | -1,025,747 | -296,654 | -11,760 | -20,000 | -849,964 |
| Purchase Of Investment | N/A | -102,708 | N/A | -76,000 | -46,800 |
| Sale Of Investment | N/A | 57,871 | N/A | 123,000 | 139,022 |
| Other Investing Activity | 214,448 | 7,299 | -107,520 | 52,000 | -697,177 |
| Investing Cash Flow | $-1,659,793 | $-1,103,719 | $-938,560 | $-1,088,000 | $-2,441,152 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,094,000 | N/A |
| Debt Repayment | N/A | N/A | N/A | -631,000 | N/A |
| Common Stock Issued | 319,638 | 65,170 | 40,880 | 56,000 | 144,528 |
| Common Stock Repurchased | -999,014 | -1,488,483 | -978,880 | -2,220,000 | -1,735,028 |
| Dividend Paid | -2,475,160 | -2,473,853 | -2,330,160 | N/A | -2,330,347 |
| Other Financing Activity | 241,181 | -35,974 | -672,000 | 134,000 | 1,139,709 |
| Financing Cash Flow | $-2,913,355 | $-3,933,140 | $-3,940,160 | $-1,567,000 | $-2,781,137 |
| Exchange Rate Effect | 233,045 | N/A | N/A | -146,000 | N/A |
| Beginning Cash Position | 2,354,279 | -1,647,498 | 987,840 | 659,000 | 1,331,037 |
| End Cash Position | 3,971,066 | -1,983,253 | 960,960 | -234,000 | 717,824 |
| Net Cash Flow | $1,383,742 | $-335,756 | $-26,880 | $405,000 | $-613,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,956,890 | 4,701,103 | 4,851,840 | 3,060,000 | 4,609,076 |
| Capital Expenditure | -902,541 | -864,415 | -868,000 | -1,226,000 | -1,117,686 |
| Free Cash Flow | 5,054,349 | 3,836,688 | 3,983,840 | 1,834,000 | 3,491,391 |